Natalia Marder, M.D., Ph.D.
Natalia Marder, M.D., Ph.D.
Dr. Natalia Marder has more than 14 years of clinical development experience in the CRO environment, including managing multiple global studies, as well as both mega-trials and small trials with niche biopharma companies. For 10 years, she has been focused on the operational management and clinical development of compounds for the treatment of numerous neurodegenerative disorders, including psychiatric diseases, neuropathies, pain, neurogenic bladder, and Parkinson’s disease (motor and non-motor symptoms). Her areas of expertise also include collaboration with the spina bifida associations and networks, controlled substance supply management, and medical review of the data collected in the clinical trials.
Dr. Marder has overseen multi-functional international teams and was recognized for successful on-time and on-budget delivery for a number of treatments, including those for unmet medical needs. As a Project Director, Dr. Marder plays a leading role in the oversight and management of both programs and individual clinical trials, Phases 1 – 4. She has collaborated with small and medium biotech companies to develop their products in advanced neurological diseases from Phase 2 proof of concept to Phase 3 programs to market approval from the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Dr. Marder strives to provide a commitment that goes beyond execution to include strategic consultation and therapeutic depth.
Her therapeutic expertise also includes various general medicine indications – vaccines, types of pneumonia and other infections, urology, endocrinology and cardiovascular diseases, as well as pediatric and ICU trials.
Dr. Marder earned her medical and doctorate degrees from Ulyanovsk State University in Russia.
Why clinical research?
“My childhood dream was to become a doctor and to make sure everyone lives until the age of 100 years old. I loved chemistry and spent my high school years in the lab, not exactly working on the elixir of life, but keeping it in mind. I only learned about clinical research – the industry that melds medicine and chemistry – while working on my Ph.D. Instantly I loved it and dove in headfirst. A challenging and fulfilling career bringing innovations in medicine closer to the people is what I always wanted, and that’s exactly what I got by choosing clinical research.”
This is what drives Dr. Marder:
“My daughter only knows one grandmother, just like me. My mother-in-law passed away at the age of 45 due to breast cancer. My grandmother passed away at the same age due to cardiomyopathy, as there were no treatments available back then. I never got to meet her, but I did get her name. And now, working with the scientific community of the world, getting to meet all the wonderful, smart and dedicated researchers … makes me believe that we will save more and more grandmothers and grandfathers, parents and children, and it’s this thought that drives me in my work every day.”